Learn how you can stall the development of full-blown Multiple Myeloma with evidence-based nutritional and supplementation therapies.
Click the orange button to the right to learn more.
The most common of these is solitary plasmacytoma of bone (SPB), accounting for 3–5% of all plasma cell malignancies. Prognostic Nomogram for Predicting Overall Survival of Solitary Bone PlasmacytomaContinue reading
“”Solitary plasmacytoma (SP) is an early-stage plasma cell malignancy that is in between monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) along the spectrumContinue reading
“…plasma cell proliferation results in a solitary lesion (solitary bone plasmacytoma or extramedullary plasmacytoma…acute cauda equina syndrome (CES) secondary to solitary bone plasmacytomaContinue reading